wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38164139-759911D5-8678-4628-83BF-F56472520BC0
Q38164139-759911D5-8678-4628-83BF-F56472520BC0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38164139-759911D5-8678-4628-83BF-F56472520BC0
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application.
P2860
Q38164139-759911D5-8678-4628-83BF-F56472520BC0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38164139-759911D5-8678-4628-83BF-F56472520BC0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0613e72b10f7501827a3d3b4f4163ba9aecdc052
P2860
Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls